Proteomics International’s (ASX:PIQ) Endometriosis Test Moves Forward With New Patent Development Kalkine
Proteomics International’s (ASX:PIQ) Endometriosis Test Moves Forward With New Patent Development kalkine.com.au
This study explored the genetic evidence linking triglyceride-related pathways and lipid-lowering drug targets with endometriosis risk and investigated the genetic association between TG levels and EM. Using genome-wide association study …
Endometriosis is a chronic, oestrogen-responsive inflammatory disease characterised by endometrial-like tissue outside the uterine cavity. Because retrograde menstruation is common, lesion establishment probably requires cellular competence and a permissive ectopic …
Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test kalkine.com.au
Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test Kalkine
Endometriosis (EMs) is a chronic gynecological disease with poorly understood pathogenesis. This study integrated lipidomics and transcriptomics to systematically investigate aberrant sphingolipid metabolism in EMs, aiming to identify pathogenic mechanisms …
Endometriosis (EM) is a chronic inflammatory gynaecological disorder affecting approximately 10% of women of reproductive age. Early diagnosis remains challenging because definitive diagnosis still relies on invasive surgical confirmation. This …
A Philadelphia-Area Biotech Just Got the Green Light for a Genomics-Guided Endometriosis Trial in the UAE BioBuzz
Medicus Wins UAE Clearance for Genomics-Guided Drug Trial MyChesCo